Epigenetics Market12

The global epigenetics market was valued at $1.0 billion in 2020, and is projected to reach $4.1 billion by 2030, growing at a CAGR of 14.8% from 2021 to 2030.

PORTLAND, OREGON, UNITED STATES, July 13, 2022 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global epigenetics market was estimated at $1.0 billion in 2020 and is expected to hit $4.1 billion by 2030, registering a CAGR of 14.8% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.

High-end technological advancements associated with epigenetics, rise in incidences of cancer, surge in genome mapping programs, and growing number of R&D activities drive the global epigenetics market. On the other hand, standardization concerns over epigenetics-based diagnostics and dearth of skilled professionals impede the growth to some extent. However, several growth opportunities in the emerging economies have created an array of lucrative prospects for the key players in the industry.

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/846

Technological advancements, rise in prevalence of cancer, and increase in genome mapping programs and number of R&D activities drive the growth of the global epigenetics market. However, standardization concerns regarding epigenetics-based diagnostics and lack of skilled professionals hamper the market growth. On the contrary, untapped potential in developing countries is expected to create lucrative opportunities for the market players in the future.

Rise in cancer prevalence; increase in funding & aids for R&D activities; rise in partnership between academic, pharmaceutical, & biotechnology companies for epigenetics studies; and increase in application of epigenetics in non-oncology diseases majorly drives the market growth. In addition, various product launch, collaborations, and other developmental strategies among key players further drive the market.

Covid-19 scenario:

Since the Covid-19 outbreak, researchers have been working to find a vaccine against Covid-19 virus. In addition, the use of targeted antiviral therapies such as rapamycin, remdesivir, ribavirin, and other epigenetic drugs have been demonstrated to inhibit the infection.

Researchers have been trying to understand how epigenetics could prevent viral proliferation, so that vaccines could be developed to specifically target the replicating mechanism of virus.

During the pandemic, the number of epigenetic research activities and awareness regarding epigenetic drugs have been increased.

Download Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/846?reqfor=covid

The kits segment to retain the lion's share-

On the basis of products, the kits segment held the major share in 2020, garnering nearly two-fifths of the global epigenetics market. Availability of an array of different kits fuels the growth of the segment. The instruments segment, on the other hand, is projected to cite the fastest CAGR of 16.3% throughout the forecast period, due to development and launch of various instruments for epigenetic purposes.

North America held the major share in 2020-

By region, the market across North America dominated in 2020, garnering nearly of the global epigenetics market, owing to rapid adoption of advanced technologies and presence of key players across North America. Simultaneously, Asia-Pacific is expected to cite the fastest CAGR of 16.3% throughout the forecast period, due to rise in R & D activities for epigenetics services and increase in healthcare investment in the region.

The growth of the global epigenetics market is attributed to increase in oncology cases, surge of other chronic diseases and its rising application for non-oncology applications. Moreover, increase in R & D for epigenetics is expected to further drive the market growth during the forecast period

Key players in the industry-

Abcam Plc.
PerkinElmer, Inc.
Zymo Research
QIAGEN N.V.
Merck Millipore
Agilent Technologies, Inc.
Illumina Inc.
Active Motif, Inc.
Hologic Inc.
Thermo Fisher Scientific Inc.

Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/846

We also Offers Regional and Country Reports-

Japan Epigenetics Market
South Korea Epigenetics Market
Singapore Epigenetics Market
China Epigenetics Market
Indonesia Epigenetics Market
Australia Epigenetics Market
Taiwan Epigenetics Market

Trending Reports in Healthcare Industry-

Prime editing and CRISPR Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Smoke Evacuation Systems Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn